Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Pediatric Acute Myocarditis
NCT07371689Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2026
- Primary completion
- Dec 2029
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute myocarditis comparing Anakinra with Placebo (2 arms). Primary endpoint: Proportion of children with recovered left ventricle ejection fraction ≥ 50% at 3 days. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
anakinra
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT07371689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07371689.